PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1544632
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1544632
AI Testing, Inspection and Certification (TIC) Services in Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
AI Testing, Inspection, and Certification (TIC) Services in Healthcare Market size is anticipated to expand at over 15% CAGR from 2024 to 2032, led by increasing launches along with integration of AI with medical devices.
As innovative devices are making their debut in the healthcare sector, TIC services have grown pivotal for ensuring AI-driven technologies adhere to stringent safety and performance benchmarks. These efforts not only propel advancements in healthcare technology but also prioritize patient well-being. To cite an example, in June 2024, Element Materials Technology unveiled RegNav, its inaugural AI-driven regulatory intelligence platform tailored for medical devices, emphasizing FDA pathways to bolster regulatory efficiency and safety.
The overall market is segregated into service, type, application, and region.
Based on type, the AI TIC services in healthcare market value from the in-house segment is estimated to rise at a notable rate from 2024 to 2032. This is fueled by the escalating demand to uphold stringent standards for AI-driven medical devices. Organizations are undertaking thorough evaluations to affirm the accuracy, safety, and reliability of these technologies for leveraging a controlled environment for meticulous testing and bespoke solutions
AI TIC services in healthcare industry size from the certification service segment is anticipated to expand at a substantial CAGR up to 2032. This expansion is driven by the increasing imperative to guarantee the reliability and safety of AI technologies. Organizations are adopting stringent certification protocols to validate the performance of AI systems in medical diagnostics and patient care on account of evolving services to tackle new challenges and uphold regulatory compliance.
Regionally, the Asia Pacific AI TIC services in healthcare market size is expected to depict robust growth between 2024 and 2032, largely attributed to escalating healthcare expenditures as well as spurring advancements in AI technologies for diagnostics, treatment, and patient management. These developments are paving the way for the integration of sophisticated AI solutions to elevate the quality and reliability of healthcare services in the region.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research design
- 1.1.1 Research approach
- 1.1.2 Data collection methods
- 1.2 Base estimates and calculations
- 1.2.1 Base year calculation
- 1.2.2 Key trends for market estimates
- 1.3 Forecast model
- 1.4 Primary research and validation
- 1.4.1 Primary sources
- 1.4.2 Data mining sources
- 1.5 Market definitions
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis, 2021-2032
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Supplier landscape
- 3.2.1 Suppliers
- 3.2.2 TIC service providers
- 3.2.3 AI technology providers
- 3.2.4 Distribution channel
- 3.2.5 End users
- 3.3 Profit margin analysis
- 3.4 Technology and innovation landscape
- 3.5 Patent analysis
- 3.6 Key news and initiatives
- 3.7 Regulatory landscape
- 3.8 Impact forces
- 3.8.1 Growth drivers
- 3.8.1.1 Growing demand for healthcare services
- 3.8.1.2 Technological advancements in AI and healthcare
- 3.8.1.3 Increasing regulatory requirements and quality standards in healthcare industry
- 3.8.1.4 Increasing complexity of medical products
- 3.8.2 Industry pitfalls and challenges
- 3.8.2.1 Complex regulatory environment
- 3.8.2.2 High initial costs and ROI uncertainty
- 3.8.1 Growth drivers
- 3.9 Growth potential analysis
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Service, 2021-2032 ($ Bn)
- 5.1 Key trends, by service
- 5.2 Testing
- 5.3 Inspection
- 5.4 Certification
- 5.5 Others
Chapter 6 Market Estimate and Forecast, By Type, 2021-2032 ($ Bn)
- 6.1 Key trends, by type
- 6.2 In-house
- 6.3 Outsourced
Chapter 7 Market Estimates and Forecast, By Application, 2021-2032 ($ Bn)
- 7.1 Key trends, by application
- 7.2 Pharmaceuticals and biotechnology
- 7.3 Clinical laboratories and diagnostics
- 7.4 Hospitals and healthcare facilities
- 7.5 Medical devices
Chapter 8 Market Estimates and Forecast, By Region, 2021-2032 ($ Bn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Russia
- 8.3.7 Nordics
- 8.3.8 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 ANZ
- 8.4.6 Southeast Asia
- 8.4.7 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of MEA
Chapter 9 Company Profiles
- 9.1 AFNOR Group
- 9.2 Apave International
- 9.3 Applus Services, S.A
- 9.4 BSI Group
- 9.5 Bureau Veritas
- 9.6 Cofrac (Comite Francais d'Accreditation)
- 9.7 DEKRA SE
- 9.8 DNV GL
- 9.9 Emitech Group
- 9.10 Eurofins Scientific
- 9.11 Expleo
- 9.12 Intertek Group PLC
- 9.13 LNE (Laboratoire National de Metrologie et d'Essais)
- 9.14 Merieux NutriSciences
- 9.15 Pharmasafe
- 9.16 QualiTest
- 9.17 SGS Group
- 9.18 TUV Rheinland
- 9.19 TUV SUD
- 9.20 UL (Underwriters Laboratories)
